By Lina carolina 
Researchers at the University of Cologne and the Centre for Genomic Regulation (CRG) in Barcelona have overturned a long-held scientific assumption about cancer, revealing that tumours grow uniformly throughout their mass, rather than exclusively at their outer edges. This groundbreaking discovery, published in the esteemed journal eLife, has profound implications for our understanding of tumour evolution, metastasis, and the development of effective cancer therapies.
The Long-Standing Paradigm: Surface-Centric Tumour Growth
For over half a century, the prevailing scientific model posited that tumours operated as a "two-speed" system. This theory proposed that the periphery of a tumour was a zone of rapid proliferation, driven by readily available oxygen and nutrients from surrounding healthy tissues. Cells at the surface, it was argued, enjoyed superior access to these essential resources and a more efficient means of waste disposal. Conversely, the core of the tumour was considered a less active region, characterized by slower cell division due to dwindling oxygen and nutrient supplies, as well as increased mechanical pressure from the surrounding mass. This hypothesis suggested that mutations and the subsequent evolution of the cancer were primarily concentrated at the tumour’s advancing frontier.
This surface-growth model has profoundly influenced cancer research, shaping hypotheses about how tumours invade tissues and spread to distant sites. It has also informed the design of early therapeutic strategies, often targeting the perceived rapid expansion at the tumour’s edge.
A New Perspective: Uniform Expansion Unveiled
The recent study, however, presents compelling evidence that directly contradicts this established view. By employing advanced spatial genomics techniques, the research team has demonstrated that cancer cells proliferate with equal vigour throughout the entire tumour volume. This means that every region within a tumour, from its centre to its periphery, is equally active and possesses the potential to harbour aggressive mutations that can drive the disease’s progression and resistance to treatment.
"We challenge the idea that a tumour is a ‘two-speed’ entity with rapidly dividing cells on the surface and slower activity in the core," stated Dr. Donate Weghorn, co-corresponding author of the study and a researcher at the Centre for Genomic Regulation in Barcelona. "Instead, we show they are uniformly growing masses, where every region is equally active and has the potential to harbour aggressive mutations."
Methodological Innovation: Spatial Genomics at the Forefront
The researchers’ paradigm-shifting findings are largely attributable to their sophisticated use of spatial genomics. This cutting-edge technique allows scientists to map the genetic landscape of cells within their precise anatomical locations in a tissue. The study leveraged data from prior investigations that had meticulously collected hundreds of small tissue samples from various locations within liver tumours, both in two and three-dimensional arrangements. This extensive sampling provided an unparalleled, detailed map of mutation distribution across the entire tumour mass.
By analyzing the genetic mutations within each of these samples, the team developed a novel computational method to quantify the direction and spread of these genetic alterations. This allowed them to calculate the precise angles between the positions of parent cells and their mutated offspring. In a surface-growth model, these angles would predominantly point outwards, reflecting expansion from the edges. However, the study’s analysis revealed a strikingly different pattern: the calculated angles were evenly distributed in all directions. This uniform dispersion of mutation angles served as irrefutable evidence of homogeneous growth throughout the tumour.
Furthermore, the distribution of mutations within the tumour provided additional corroborating evidence. If cancer cells were predominantly dividing at the edges, mutations would be expected to be clustered in those peripheral regions. Instead, the researchers observed a widespread distribution of mutations, strongly suggesting that cell division was occurring uniformly across the entire tumour.
Computational Validation: Simulating Tumour Dynamics
To rigorously validate their empirical findings, the researchers also turned to computational simulations. They created virtual tumour models, systematically generating two distinct scenarios: one simulating surface growth and another simulating uniform volume growth. The patterns of mutations observed in these virtual tumours were then compared to the patterns identified in the real liver tumour data. The results were unequivocal: the mutation patterns from the actual tumours closely mirrored those generated by the volume growth simulations, while deviating significantly from the surface growth simulations. This computational reinforcement further solidified the study’s conclusion of uniform tumour expansion.
Broader Implications for Cancer Evolution and Treatment
The implications of this discovery are far-reaching, particularly concerning tumour evolution and the development of therapeutic resistance. The constant turnover of dying and regenerating cells throughout the entire tumour mass presents cancer with numerous opportunities for "evolutionary innovations." These innovations can include the acquisition of mutations that enable the cancer to evade immune surveillance, a critical step in its ability to spread and persist.
"Our findings have implications for tumour evolution," explained Prof. Johannes Berg, co-corresponding author and researcher at the University of Cologne. "The constant churn of cells dying and being replaced by new ones throughout the tumour volume gives cancer many opportunities for evolutionary innovations, such as escaping from immune surveillance."
This new understanding suggests that therapeutic strategies that solely target the perceived active edges of a tumour might be less effective than previously thought. If all regions of the tumour are equally capable of generating aggressive cell populations, then a more comprehensive approach to treatment may be necessary to eradicate the disease effectively. This could involve therapies that can penetrate and affect all parts of the tumour, or strategies that aim to disrupt the uniform growth mechanism itself.
Limitations and Future Directions
While the study’s findings are groundbreaking, the researchers acknowledge certain limitations. The current research primarily focused on liver cancer. Therefore, it remains to be determined whether this uniform growth model applies universally to all cancer types. Different cancers have distinct genetic backgrounds, microenvironments, and growth characteristics, which could influence their expansion patterns.
Another important consideration is the study’s focus on the early stages of tumour growth. Larger, more advanced, or metastatic tumours may exhibit different growth dynamics. The increased complexity and heterogeneity of these later-stage cancers could potentially alter the uniformity of cell division.
"The emergence of mutants that confer resistance to therapy are an important aspect of clinical relevance," concluded Dr. Berg. "Our work focuses on early-stage tumour growth, but expanding the research to late-arising mutations can tell us more about those mutations and why they ultimately foil many therapeutic approaches."
Future research will undoubtedly aim to address these limitations by investigating the growth patterns of a wider array of cancer types and at different stages of disease progression. Understanding how mutations that confer therapy resistance arise and are distributed within these uniformly expanding tumours will be crucial for developing more robust and effective treatment strategies in the future. This paradigm shift in understanding tumour growth marks a significant advancement in the ongoing battle against cancer, opening new avenues for research and ultimately, for patient care.
